Legal Representation
Attorney
Julie A. Greenberg
Application History
36 eventsDate | Code | Type | Description |
---|---|---|---|
May 6, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
May 6, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Mar 11, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Mar 11, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION |
Mar 11, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Mar 11, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION |
Mar 5, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Mar 5, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Feb 19, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Feb 19, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
Feb 19, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Feb 19, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
Feb 19, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
Feb 19, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Feb 19, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
Feb 19, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Feb 19, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
Feb 19, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
Jan 7, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Jan 7, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Jan 6, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Jan 6, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Jan 6, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Jan 6, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Oct 30, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED |
Oct 30, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN |
Oct 30, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Oct 30, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED |
Oct 30, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN |
Oct 30, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Oct 23, 2024 | DOCK | D | ASSIGNED TO EXAMINER |
Oct 23, 2024 | DOCK | D | ASSIGNED TO EXAMINER |
Sep 21, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Sep 21, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Apr 10, 2024 | NWAP | I | NEW APPLICATION ENTERED |
Apr 10, 2024 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 009
Downloadable data sets, reports, and electronic publications in the nature of periodic reports, newsletters, and periodic industry guidelines in the field of medicine, therapeutics, pharmacology, pharmaceuticals, medical market access, and medical and pharmaceutical economics; Downloadable data sets, reports, and electronic publications in the nature of periodic reports, newsletters, and periodic industry guidelines in the fields of medical and pharmaceutical businesses, medical and pharmaceutical commerce, medical and pharmaceutical pricing, medical market access, pharmaceutical distribution, scientific research, medicine, pharmacology, medical diagnostics, and drugs
Class 035
Business and commercial pharmaceutical market analysis and information services; Gathering, monitoring, compiling, analyzing, and providing business and commercial information, news, and insights in the nature of providing business and commercial information in the fields of medicine, therapeutics, pharmacology, pharmaceuticals, medical diagnostics, pharmaceutical distribution, medical market access, and medical and pharmaceutical markets, and medical and pharmaceutical economics; Providing business information, data, and analytics in the field of pharmaceutical markets in the nature of providing business and commercial information providing business information and market analysis services in the field of pharmaceuticals
Class 036
Gathering, monitoring, compiling, analyzing, and providing financial and insurance information, news, and insights in the nature of financial and insurance information in the fields of medicine, therapeutics, pharmacology, pharmaceuticals, medical diagnostics, pharmaceutical distribution, medical market access, medical and pharmaceutical markets, and medical and pharmaceutical economics; providing financial and insurance information, data, and analytics in the nature of financial and insurance information in the field of pharmaceuticals and pharmaceutical markets; Financial analysis and insurance information services in the field of pharmaceutical markets
Class 042
Gathering, monitoring, compiling, analyzing, and providing scientific and scientific research information, news, and insights in the nature of providing scientific information and scientific research information in the fields of medicine, therapeutics, pharmacology, pharmaceuticals, medical diagnostics, pharmaceutical distribution, medical market access, medical and pharmaceutical markets, and medical and pharmaceutical economics; Software as a service (SAAS) featuring software for providing monitoring, analytics, modeling, information, data, news, and insights in the fields of medicine, therapeutics, pharmacology, pharmaceuticals, medical diagnostics, pharmaceutical distribution, medical market access, and medical and pharmaceutical markets, and regarding business, commerce, finance, scientific research, and medical and pharmaceutical economics; Providing scientific and scientific research information, data, and analytics in the nature of providing scientific information and scientific research information regarding pharmaceuticals; Scientific and scientific research information analysis services in the nature of providing scientific information, scientific research information and scientific analysis in the field of pharmaceuticals; Software as a service (SAAS) featuring software for providing information, data, and analytics regarding pharmaceuticals and market, distribution, pricing, market access, and economic information related to pharmaceuticals
Class 044
Medical information relating to medical, therapeutic, pharmacological, and pharmaceutical fields; Medical information and medical analysis relating to medical, therapeutic, pharmacological, and pharmaceutical fields for diagnostic and treatment purposes provided by medical laboratories; Gathering, monitoring, compiling, analyzing, and providing medical, therapeutic, pharmacological, pharmaceutical, and medical diagnostic information, news, and insights in the nature of medical information in the fields of pharmaceutical distribution, medical market access, medical and pharmaceutical markets, and medical and pharmaceutical economics; Providing medical research information in the field of pharmaceuticals
Classification
International Classes
009
035
036
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"ACCESS"
Specific Disclaimer
"ACCESS"